1、Financial ReportOverviewFinancial ReportESG DisclosuresBusiness ReportGovernance,Compensation&RiskIntegrated Annual Report 20249293 Performance overview99 Consolidated financial statements of the Group152 Audit report for the consolidated financial statements of the Group154 Supplementary financial
2、information161 Financial statements of Sandoz Group AG169 Audit report for the financial statements of Sandoz Group AG Change Change Change(USD millions unless indicated otherwise)2024 2023 in USD in%in cc%1Net sales to third parties 10,357 9,647 710 7 9 EBITDA 820 914 (94)(10)(1)Core EBITDA 2,080 1
3、,743 337 19 24 Core EBITDA margin(%)20.1 18.1 Operating income 307 375 (68)(18)5 Core operating income 1,821 1,488 333 22 28 Net income 1 80 (79)(99)(109)Core net income 1,176 953 223 23 28 Diluted earnings per share(USD)0.00 0.18 (0.18)(100)(110)Core diluted earnings per share(USD)2.71 2.20 0.51 23
4、 28 Free cash flow 98 (234)332 Management free cash flow 1,112 99 1,013 Net debt 3,329 3,115 214 Net debt to core EBITDA ratio 1.6x 1.8x Core ROIC(%)12.3 9.8 1 In constant currencies.Performance overviewSandoz delivered strong financial results in 2024,underpinned by continued momentum in the biosim
5、ilar business and progress in our journey as a standalone company.NET SALES TO THIRDPARTIESUSD10.4bn+9%in constant currenciesCORE EBITDA MARGIN20.1%+200 basis pointsMANAGEMENT FREE CASH FLOWUSD1.1bn+USD 1.0 billion OPERATING INCOMEUSD307m+5%in constant currenciesCORE DILUTED EPSUSD2.71+28%in constan
6、t currenciesCORE ROIC12.3%+250 basis points An explanation of non-IFRS measures as defined by Sandoz,including core EBITDA,core net income,core diluted earnings per share,free cash flow,management free cash flow,net debt and the reconciliation of core results can be found in the section“Supplementar